Eastern Regional Health Authority

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Irritable bowel syndrome1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Ottawa Hospital Research Institute1 trial
• Seagen, a wholly owned subsidiary of Pfizer1 trial
• Société des Produits Nestlé (SPN)1 trial
• Swedish Orphan Biovitrum1 trial

Running trials

• Active, not recruiting

  Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

  NCT04404283· Phase 3· Seagen, a wholly owned subsidiary of Pfizer· Source

• Active, not recruiting

  A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

  NCT03165734· Phase 3· Swedish Orphan Biovitrum· Source

Closed trials

• Completed

  IBD Neoplasia Surveillance RCT

  NCT05809999· Ottawa Hospital Research Institute· Source

• Completed

  A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome

  NCT05054309· Société des Produits Nestlé (SPN)· Source